Kestra Investment Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Sell
7,288
-1,325
-15% -$275K 0.03% 156
2026
Q1
$1.82M Buy
8,613
+7,535
+699% +$1.62M 0.03% 142
2025
Q4
$222K Buy
+1,078
New +$203K 0.01% 407
2025
Q3
Sell
-4,482
Closed -$617K 516
2025
Q2
$617K Hold
4,482
0.01% 349
2025
Q1
$617K Buy
4,482
+1,218
+37% +$155K 0.02% 241
2024
Q4
$386K Buy
3,264
+1,437
+79% +$168K 0.02% 273
2024
Q3
$202K Buy
+1,827
New +$191K 0.01% 336

Other funds holding CAH

Kestra Investment Management's CAH Position: Q2 2026 in Review

Kestra Investment Management reduced its Cardinal Health (CAH) stake by 15% in Q2 2026, selling an estimated $275K and leaving 7,288 shares worth $1.73M. The position accounts for 0.03% of the portfolio, ranked #156.

Kestra Investment Management first reported a position in CAH in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.82M in Q1 2026. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Kestra Investment Management held 7,288 shares of Cardinal Health worth $1.73M as of Q2 2026.
  • Kestra Investment Management sold 1,325 Cardinal Health shares in Q2 2026, an estimated $275K.
  • Cardinal Health made up 0.03% of Kestra Investment Management's portfolio in Q2 2026, its #156 holding.
  • Kestra Investment Management first reported a position in Cardinal Health in Q3 2024 and has held it in 7 quarters since.
  • Kestra Investment Management's Cardinal Health position peaked at $1.82M in Q1 2026.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.